Safe Transport Algorithm and TRIPS in Neonatal Transport (TRIPS)

January 23, 2026 updated by: Beste Ozguven Oztornaci

Improving Neonatal Transport Knowledge of Neonatal Intensive Care Unit Nurses and Physicians Using a Safe Transport Algorithm and Physiological Stability Transport Risk Index: A Quasi-experimental Study

Aim: Newborn babies may need to be referred to different centers to receive the care they need. It is important to improve the quality of neonatal transport to reduce infant mortality rates. This study was conducted to examine the effect of the use of transport algorithm and TRIPS (Transport Risk Index of Physiological Stability) on the knowledge level of nurses and physicians working in the neonatal intensive care unit.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Detailed Description

The following hypotheses were tested within the scope of the research:

H1: Using structured educational interventions that include the "Safe Transport Algorithm" increases the knowledge level of neonatal nurses and physicians regarding neonatal transport.

H2: Using structured educational interventions that include the "Transport Physiological Stability Risk Index (TRIPS)" increases the knowledge level of neonatal nurses and physicians regarding neonatal transport.

Study Type

Interventional

Enrollment (Actual)

100

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • Turkey (Türkiye)
    • ÇİĞLİ
      • Izmir, ÇİĞLİ, Turkey (Türkiye), 35620
        • İzmir Katip Çelebi University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • Accepting to participate voluntarly in the study and working as a nurse or physician in the neonatal intensive care unit.

Exclusion Criteria:

  • Change in the participant's workplace during the data collection process.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Basic Science
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: involving a total of 100 volunteer healthcare professionals, including 72 nurses and 28 physicians
Pre-intervention, data were collected in two stages, before and after training, using a 33-item "Newborn Transport Knowledge Assessment Form" developed by researchers and validated based on expert opinions. As part of the intervention, a 10-step safe transport algorithm developed by researchers and validated by expert opinion, along with TRIPS, was displayed in clinical areas, and verbal training was provided to participants. Post intervention, data were collected in two stages, before and after training, using a 33-item "Newborn Transport Knowledge Assessment Form".
Behavioral: As part of the intervention, a 10-step safe transport algorithm developed by researchers and validated by expert opinion, along with TRIPS, was displayed in clinical areas, and verbal training was pro
In this intervention, a 10-step safe transport algorithm developed by researchers and approved by expert opinion was used. In addition, the TRIPS index, which was not used as standard practice at the clinic where the research was conducted, began to be used as part of the intervention.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Knowledge Level Assessment Form on Neonatal Transport Form
Time Frame: 1 month
This form has been developed by researchers in line with the relevant literatüre. The form consists of a total of 33 items aimed at assessing the level of knowledge regarding newborn transport. Participants were asked to select one of the options "true," "false," or "I don't know" for each item. Correct answers are worth 1 point, while incorrect answers and "I don't know" responses are worth 0 points. The total possible score on the form ranges from 0 to 33. In order to evaluate the validity of the forms, the final version of the forms was determined by consulting experts. The minimum Coverage Validity Ratio (CVR) is accepted as 0.99. The 19 items with low CVR values were revised and resubmitted to the experts for approval. As a result of the final evaluation, the Content Validity Index calculated based on the CVR average of the items was found to be 1.00, and it was determined that the content validity of the form was statistically sufficient.
1 month

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Beste Ozguven Oztornaci

Collaborators

Izmir Katip Celebi University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

June 1, 2022

Primary Completion (Actual)

April 1, 2023

Study Completion (Actual)

February 8, 2024

Study Registration Dates

First Submitted

January 11, 2026

First Submitted That Met QC Criteria

January 23, 2026

First Posted (Actual)

January 30, 2026

Study Record Updates

Last Update Posted (Actual)

January 30, 2026

Last Update Submitted That Met QC Criteria

January 23, 2026

Last Verified

January 1, 2026

More Information

Terms related to this study

Keywords

Other Study ID Numbers

  • 22.09.2022/0379

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Newborn

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Mozambique

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Subscribe